Product Information

CARBAMAZEPINE 200 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1190 per EA under NDC 51672400503. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Oct 3, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARBAMAZEPINE 200 MG TABLET

Carbamazepine
$0.1190per EA

Strength

200 mg/1

NDC

51672400503

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARBAMAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA074649

FDA Approved

10/3/1996

TE Code

AB

On Market Since

10/3/1996

Pharmacological Classes

Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity
Mood Stabilizer

Price Statistics

The NADAC for CARBAMAZEPINE 200 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 209.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1190 per EA
All-time high$0.7627 (Dec 10, 2014)
All-time low$0.0384 (Nov 28, 2013)
52-week high$0.1261
52-week low$0.1157
Median price$0.2867
Average price$0.3298
Largest weekly change+478.8% (Jul 16, 2014)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+1.7%

1M

+1.7%

3M

-4.0%

6M

+1.6%

1Y

-4.3%

3Y

-24.3%

5Y

-55.4%

All

+209.7%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CARBAMAZEPINE 200 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CARBAMAZEPINE 200 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.1190 per EA (NDC 51672400503), effective Aug 19, 2026.

How has the price of CARBAMAZEPINE 200 MG TABLET changed over time?

Over the history we have for it, the NADAC for CARBAMAZEPINE 200 MG TABLET has risen 209.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CARBAMAZEPINE 200 MG TABLET?

Since Nov 28, 2013, the NADAC for CARBAMAZEPINE 200 MG TABLET has ranged from a low of $0.0384 (Nov 28, 2013) to a high of $0.7627 (Dec 10, 2014), with a median of $0.2867 per EA.

Are there cheaper alternatives to CARBAMAZEPINE 200 MG TABLET?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CARBAMAZEPINE 200 MG TABLET, is $0.1170 per EA — about 2% below CARBAMAZEPINE 200 MG TABLET.

Who manufactures CARBAMAZEPINE 200 MG TABLET?

CARBAMAZEPINE 200 MG TABLET (NDC 51672400503) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.